申请人:Exegenics Inc.
公开号:US06828350B1
公开(公告)日:2004-12-07
The present invention concerns novel mediators of the activity of picornavirus 3C protease and the modulation of the activity of other similar proteins. The modulators may be used in pharmaceutical compositions either for inhibition of 3C protease (for example in viral infections) or for the enhancement of the activity of proteins similar to the 3C protease such as Apopain (for induction of apoptosis).
本发明涉及对小RNA病毒3C蛋白酶活性的新型调节剂以及对其他类似蛋白的活性进行调节。这些调节剂可用于制备药物组合物,用于抑制3C蛋白酶的活性(例如在病毒感染中),或用于增强类似于3C蛋白酶的蛋白的活性,如Apopain(用于诱导凋亡)。